Sinai Medical Center is categorized under Rheumatologists in Los Angeles, CA and active since 2006.
Sinai Medical Center was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael H Weisman at the company’s single location by writing to 8700 Beverly Boulevard B131, Los Angeles, California CA 90048 or by phoning (310) 423-2170. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Sinai Medical Center |
Contact Person: | Michael H Weisman |
Address: | 8700 Beverly Boulevard B131, Los Angeles, California 90048 |
Phone Number: | (310) 423-2170 |
Website Address: | cedars-sinai.edu |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rheumatologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Sinai Medical Center was started in 2006 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael H Weisman for inquiries that concern Sinai Medical Center by calling the company number (310) 423-2170, as your correspondence is most welcome. Additionally, the physical location of the single location of Sinai Medical Center can be found at the coordinates 34.076703,-118.38057 as well as the street address 8700 Beverly Boulevard B131 in Los Angeles, California 90048.
For its online presence, you may visit Sinai Medical Center’s website at cedars-sinai.edu and engage with its social media outlets through on Twitter and on Facebook.